...
首页> 外文期刊>ChemMedChem >Therapeutic Links between Alzheimer's Disease and Brain Cancer: Drug Discovery Consequences
【24h】

Therapeutic Links between Alzheimer's Disease and Brain Cancer: Drug Discovery Consequences

机译:阿尔茨海默氏病和脑癌之间的治疗联系:药物发现的后果

获取原文
获取原文并翻译 | 示例
           

摘要

It was recently reported that female survivors of breast cancer have a lower risk of Alzheimer's disease (AD). This observation led to the hypothesis that there is a link between cancer and AD. This Viewpoint provides an analysis of the consequences of this hypothesis, not only from the perspective of drug discovery for new treatments, but above all, the awareness that any AD chemotherapy will require drug administration over longer periods of time before any cognitive effects are observed., Because such drugs will probably act as neuroprotecfive agents, slowing the progression of AD rather than curing it, they should be prescribed as soon as the first AD symptoms are detected. After a general survey of anticancer drugs that have potential therapeutic value for AD .chemotherapy, new drugs that could affect specific signal transduction pathways known to be activated by anticancer drugs are presented, with the unfolding protein response pathway being one of the most relevant biological targets, for new AD chemotherapeutic agents.
机译:最近有报道称,女性乳腺癌幸存者患阿尔茨海默氏病(AD)的风险较低。该观察结果提出了以下假设:癌症与AD之间存在联系。该观点不仅从新疗法的药物发现角度分析了这一假设的后果,而且最重要的是,认识到任何AD化疗都需要较长时间的药物管理才能观察到任何认知作用。由于此类药物可能会充当神经保护剂,从而减慢AD的进程而不是治愈它,因此,应在发现第一个AD症状后立即开具处方。在对可能对AD化学疗法具有治疗价值的抗癌药物进行了全面调查之后,提出了可能影响已知被抗癌药物激活的特定信号转导途径的新药物,其中正在展开的蛋白质反应途径是最相关的生物学靶标之一,用于新型AD化疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号